🌟 Supporting Rare Disease Day 2025 🌟
February 28, 2025
At
Pharmidex, we stand in solidarity with patients, families, and researchers on
Rare
Disease
Day.
Today, we reinforce our commitment to advancing drug discovery and development for rare diseases because every patient deserves hope, innovation, and better treatment options.
With our expertise in in silico drug discovery, ADME-PK, bioanalysis, and preclinical research, we work tirelessly to support biotech and pharma companies in their mission to bring life-changing therapies to those affected by rare conditions.
Together, we can accelerate progress and make a difference. 💙✨
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
